Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408518 · ClinicalTrials.gov registry record · NA
Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes
A NA study of Gut Health and Digestive Disease, sponsored by Synbiotic Health.
- Recruiting
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT07408518 is a NA study of Gut Health and Digestive Disease that is actively recruiting participants, run by Synbiotic Health. The registered enrollment target is 92 participants, above the 52-participant average among 9 other Gut Health trials with a reported enrollment target (77% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07408518, a NA study of Gut Health and Digestive Disease, is actively recruiting participants, sponsored by Synbiotic Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team is conducting a consumer-driven, decentralized clinical research study to assess the impact of the consumer-grade probiotic supplement, iVS-1, on adults with moderate to severe gastrointestinal discomfort. Bifidobacterium adolescentis iVS-1 was chosen for its association with gastrointestinal health benefits and its safety profile, having been self-affirmed as GRAS and lacking antibiotic resistance and virulence genes. The study aims to evaluate the probiotic's effects not only on gastrointestinal symptoms but also on secondary outcomes like sleep disturbance, sleep quality, daytime alertness, anxiety, stress, and gut microbiota. This will be accomplished using self-reported outcome questionnaires, daily surveys, and at-home stool collection over a period of up to 17 weeks. There is no "doctor-patient" relationship, as participants are making an informed choice to take the product as consumers and participate in the process. Findings will contribute to knowledge about the probiotic's tolerability, formulation, and the design of future studies.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Probiotic
Study Locations (1)
California
- People Science, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2026-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07408518
The ClinicalTrials.gov registry entry for NCT07408518 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 52-participant average among 9 other Gut Health trials with a reported enrollment target (77% higher). The listed sponsor is Synbiotic Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gut Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07408518 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07408518 about?
NCT07408518 is a clinical study titled "Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes". The study team is conducting a consumer-driven, decentralized clinical research study to assess the impact of the consumer-grade probiotic supplement, iVS-1, on adults with moderate to severe gastrointestinal discomfort. Bifidobacterium adolescentis iVS-1 was chosen for its association with gastroin...
What is the current status of trial NCT07408518?
This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2026-01-20. Estimated completion is 2026-09-23.
What conditions does trial NCT07408518 study?
This clinical trial studies the following conditions: Gut Health, Digestive Disease.
What interventions are being tested in trial NCT07408518?
The interventions under investigation include: Placebo (OTHER), Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07408518?
This trial is sponsored by Synbiotic Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408518 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System
RECRUITING · NA
-
The Effect Cranberry-Based Products on the Female Microbiome
RECRUITING · NA
-
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes
RECRUITING · NA
-
Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability
RECRUITING · NA
-
A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms
RECRUITING · NA
-
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.